Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements
Journal of Alzheimer’s Disease · 30.07.2024 · 100 (3) · 843-862
DOI: 10.3233/jad-231321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 28.06.2024. Verfasst von Xiaowei Zhuang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Magnetic Resonance Imaging, Machine Learning. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Computer-aided machine learning models are being actively developed with clinically available biomarkers to diagnose Alzheimer’s disease (AD) in living persons. Despite considerable work with cross-sectional in vivo data, many models lack validation against postmortem AD neuropathological data.
Objective
Train machine learning models to classify the presence or absence of autopsy-confirmed severe AD neuropathology using clinically available features.
Methods
AD neuropathological status are assessed at postmortem for participants from the National Alzheimer’s Coordinating Center (NACC). Clinically available features are utilized, including demographics, Apolipoprotein E(APOE) genotype, and cortical thicknesses derived from ante-mortem MRI scans encompassing AD meta regions of interest (meta-ROI). Both logistic regression and random forest models are trained to identify linearly and nonlinearly separable features between participants with the presence ( N = 91, age-at-MRI = 73.6±9.24, 38 women) or absence ( N = 53, age-at-MRI = 68.93±19.69, 24 women) of severe AD neuropathology. The trained models are further validated in an external data set against in vivo amyloid biomarkers derived from PET imaging (amyloid-positive: N = 71, age-at-MRI = 74.17±6.37, 26 women; amyloid-negative: N = 73, age-at-MRI = 71.59±6.80, 41 women).
Results
Our models achieve a cross-validation accuracy of 84.03% in classifying the presence or absence of severe AD neuropathology, and an external-validation accuracy of 70.14% in classifying in vivo amyloid positivity status.
Conclusions
Our models show that clinically accessible features, including APOE genotype and cortical thinning encompassing AD meta-ROIs, are able to classify both postmortem confirmed AD neuropathological status and in vivo amyloid status with reasonable accuracies. These results suggest the potential utility of AD meta-ROIs in determining AD neuropathological status in living persons.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.
- Interdisciplinary Neuroscience PhD Program, University of Nevada, Las Vegas, NV, USA.
- Laboratory of Neurogenetics and Precision Medicine, University of Nevada, Las Vegas, NV, USA.
- University of Colorado Boulder, Boulder, CO, USA.
- Department of Biostatistics and Epidemiology, School of Public Health, University of North Texas Health Science Center, Fort Worth, TX, USA.
- Department of Internal Medicine, School of Medicine, University of Nevada, Las Vegas, NV, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Zhuang, X., Cordes, D., Bender, A. R., Nandy, R., Oh, E. C., Kinney, J., Caldwell, J. Z. K., Cummings, J., & Miller, J. (2024). Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements. Journal of Alzheimer’s Disease, 100(3), 843-862. https://doi.org/10.3233/jad-231321
Vancouver
Zhuang X, Cordes D, Bender AR, Nandy R, Oh EC, Kinney J, et al. Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements. Journal of Alzheimer’s Disease. 2024;100(3):843-862. doi:10.3233/jad-231321
BibTeX
@article{Zhuang2024,
author = {Zhuang, Xiaowei and Cordes, Dietmar and Bender, Andrew R and Nandy, Rajesh and Oh, Edwin C and Kinney, Jefferson and Caldwell, Jessica Z K and Cummings, Jeffrey and Miller, Justin},
title = {Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
volume = {100},
number = {3},
pages = {843--862},
doi = {10.3233/jad-231321}
}
EUVIMED